The ratio between sialyltransferases and neuraminidases (ST6GAL1/NEU1 and ST3GAL6/NEU1), which describes the terminal sialylation levels, was found to be increased in T cells from SLE patients. Here, NEU1 is linked to systemic lupus erythematosus.